Zhende Medical Co Ltd (603301) - Net Assets

Latest as of September 2025: CN¥5.99 Billion CNY ≈ $875.85 Million USD

Based on the latest financial reports, Zhende Medical Co Ltd (603301) has net assets worth CN¥5.99 Billion CNY (≈ $875.85 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥8.40 Billion ≈ $1.23 Billion USD) and total liabilities (CN¥2.42 Billion ≈ $354.01 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 603301 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	CN¥5.99 Billion
% of Total Assets	71.22%
Annual Growth Rate	49.49%
5-Year Change	32.0%
10-Year Change	2146.71%
Growth Volatility	69.7

Zhende Medical Co Ltd - Net Assets Trend (2014–2024)

This chart illustrates how Zhende Medical Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore 603301 total assets for the complete picture of this company's asset base.

Annual Net Assets for Zhende Medical Co Ltd (2014–2024)

The table below shows the annual net assets of Zhende Medical Co Ltd from 2014 to 2024. For live valuation and market cap data, see market value of Zhende Medical Co Ltd.

Year	Net Assets	Change
2024-12-31	CN¥5.90 Billion ≈ $862.83 Million	+5.21%
2023-12-31	CN¥5.60 Billion ≈ $820.10 Million	-2.65%
2022-12-31	CN¥5.76 Billion ≈ $842.43 Million	+29.67%
2021-12-31	CN¥4.44 Billion ≈ $649.65 Million	-0.61%
2020-12-31	CN¥4.47 Billion ≈ $653.65 Million	+219.14%
2019-12-31	CN¥1.40 Billion ≈ $204.82 Million	+24.45%
2018-12-31	CN¥1.12 Billion ≈ $164.57 Million	+100.76%
2017-12-31	CN¥560.19 Million ≈ $81.97 Million	+27.85%
2016-12-31	CN¥438.18 Million ≈ $64.12 Million	+66.96%
2015-12-31	CN¥262.45 Million ≈ $38.40 Million	+148.13%
2014-12-31	CN¥105.77 Million ≈ $15.48 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Zhende Medical Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 339202133626.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component	Amount	Percentage
Retained Earnings	CN¥3.38 Billion	59.86%
Common Stock	CN¥266.45 Million	4.72%
Other Comprehensive Income	CN¥233.51 Million	4.14%
Other Components	CN¥1.77 Billion	31.28%
Total Equity	CN¥5.64 Billion	100.00%

Zhende Medical Co Ltd Competitors by Market Cap

The table below lists competitors of Zhende Medical Co Ltd ranked by their market capitalization.

Company	Market Cap
Camurus AB ST:CAMX	$3.63 Billion
Gitlab Inc NASDAQ:GTLB	$3.63 Billion
Tibet Huayu Mining Co Ltd SHG:601020	$3.64 Billion
Baytex Energy Corp TO:BTE	$3.64 Billion
Enova International Inc NYSE:ENVA	$3.63 Billion
ELF Beauty Inc NYSE:ELF	$3.63 Billion
PT Indofood Sukses Makmur Tbk JK:INDF	$3.63 Billion
Rubis SCA PA:RUI	$3.63 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Zhende Medical Co Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 5,365,596,147 to 5,643,251,376, a change of 277,655,229 (5.2%).
Net income of 385,170,729 contributed positively to equity growth.
Dividend payments of 159,395,258 reduced retained earnings.
Other comprehensive income increased equity by 233,510,910.
Other factors decreased equity by 181,631,152.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	CN¥385.17 Million	+6.83%
Dividends Paid	CN¥159.40 Million	-2.82%
Other Comprehensive Income	CN¥233.51 Million	+4.14%
Other Changes	CN¥-181.63 Million	-3.22%
Total Change	CN¥-	5.17%

Book Value vs Market Value Analysis

This analysis compares Zhende Medical Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 4.39x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 137.66x to 4.39x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2014-12-31	CN¥0.68	CN¥93.28	x
2015-12-31	CN¥1.77	CN¥93.28	x
2016-12-31	CN¥2.99	CN¥93.28	x
2017-12-31	CN¥3.80	CN¥93.28	x
2018-12-31	CN¥6.23	CN¥93.28	x
2019-12-31	CN¥6.93	CN¥93.28	x
2020-12-31	CN¥20.51	CN¥93.28	x
2021-12-31	CN¥17.95	CN¥93.28	x
2022-12-31	CN¥23.35	CN¥93.28	x
2023-12-31	CN¥20.01	CN¥93.28	x
2024-12-31	CN¥21.24	CN¥93.28	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Zhende Medical Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 6.83%
The company has moderate efficiency in generating returns from equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 9.03%
• Asset Turnover: 0.56x
• Equity Multiplier: 1.34x
Recent ROE (6.83%) is below the historical average (19.52%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2014	21.97%	2.21%	0.89x	11.20x	CN¥11.86 Million
2015	30.57%	7.74%	0.80x	4.93x	CN¥53.19 Million
2016	18.94%	8.00%	0.92x	2.58x	CN¥39.10 Million
2017	21.77%	9.32%	1.01x	2.31x	CN¥65.85 Million
2018	11.59%	9.11%	0.77x	1.65x	CN¥17.83 Million
2019	11.55%	8.40%	0.70x	1.96x	CN¥21.01 Million
2020	60.95%	24.52%	1.62x	1.53x	CN¥2.13 Billion
2021	14.65%	11.70%	0.79x	1.58x	CN¥189.19 Million
2022	12.27%	11.08%	0.78x	1.43x	CN¥125.71 Million
2023	3.70%	4.81%	0.57x	1.35x	CN¥-338.16 Million
2024	6.83%	9.03%	0.56x	1.34x	CN¥-179.15 Million

Industry Comparison

This section compares Zhende Medical Co Ltd's net assets metrics with peer companies in the Medical Instruments & Supplies industry.

Industry Context

Industry: Medical Instruments & Supplies
Average net assets among peers: $1,585,373,438
Average return on equity (ROE) among peers: 5.47%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Zhende Medical Co Ltd (603301)	CN¥5.99 Billion	21.97%	0.40x	$3.63 Billion
Beijing Centergate Technologies Holding Co Ltd (000931)	$1.79 Billion	0.80%	1.04x	$521.28 Million
Blue Sail Medical Co Ltd (002382)	$203.26 Million	29.44%	0.87x	$1.08 Billion
Andon Health Co Ltd (002432)	$1.54 Billion	0.94%	0.53x	$4.93 Billion
Allmed Medical Products Co Ltd Class A (002950)	$3.13 Billion	12.99%	0.84x	$1.34 Billion
Guangzhou Improve Med Instrument (300030)	$563.53 Million	4.77%	0.17x	$380.05 Million
QITIAN Technology Group Co Ltd (300061)	$1.16 Billion	-31.55%	0.49x	$950.81 Million
Shanghai Tofflon Science Tech (300171)	$3.12 Billion	2.26%	0.50x	$1.47 Billion
Truking Technology Ltd (300358)	$2.32 Billion	6.92%	0.71x	$1.03 Billion
Jiangxi Sanxin Medtec Co Ltd (300453)	$1.33 Billion	15.49%	0.52x	$782.31 Million
Shenyang Xingqi Pharmaceutical Co Ltd (300573)	$694.06 Million	12.68%	0.39x	$2.51 Billion

About Zhende Medical Co Ltd

SHG:603301 China Medical Instruments & Supplies

Market Cap

$3.63 Billion

CN¥24.80 Billion CNY

Market Cap Rank

#4435 Global

#798 in China

Share Price

CN¥93.28

Change (1 day)

+1.06%

52-Week Range

CN¥19.42 - CN¥100.22

All Time High

CN¥100.22